Smoking Cessation Intervention for Women Living With HIV

Completed · Not applicable

Conditions studied: AIDS/HIV

In brief

As people with HIV/AIDS live longer, the burden of non-AIDS-related health problems such as cardiovascular diseases and cancers on these people have consistently increased. Smoking is one of the major contributing factors to these health problems and rates of cigarette smoking in this group are substantially higher than those of the general population: 40-70% vs. 17-10%. Especially, women living with HIV/AIDS seem to be more susceptible to the negative consequence of smoking than their male counterparts. They are also less likely to see tobacco dependence treatment for dual stigma associated with both conditions: HIV infection and nicotine addiction. This is a pilot study to develop smoking cessation intervention for these women.

Key facts

Study ID

NCT02898597

Run by

University of Massachusetts, Boston

People needed

49

Starts

2016-06-01

Expected to finish

2018-08-31

Last updated by the study team

2019-08-05

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• English speaking
• Diagnosis of HIV infection
• Age 18 or older
• Smoking at least 5 cigarettes a day
• Having access to a mobile-phone with Internet connection
• Willing to quit smoking within the next 4 weeks

You may not qualify if…

• Inability to speak English
• Involvement in another cessation program
• Being pregnant or lactating
• Having an active skin disease
• History of serious mental illnesses (e.g., schizophrenia and bipolar disorder)
• Serious alcohol use problem
• Use of any illegal substances excluding marijuana

Where it is running

• University Massachusetts Boston — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.